Skip to content
Back
Most popular
-
Read more
Our latest edition of Vision Voice is here
Welcome to the latest edition of Vision Voice.
-
Read more
Opinion Editorial: Sight preservation should be a national priority
By The Hon. Jillian Skinner, AM, former NSW Minister for Health.This article was originally published by News Corp.
Read moreRead our latest newsletter today
Welcome to our final Vision Voice newsletter for the year.
-
Read more
Survey shows new Eye Connect service benefiting AMD community
MDFA has received a positive response from the people participating in our new Eye Connect support service.
Read moreMDFA showcases groundbreaking research projects in new impact report
Macular Disease Foundation Australia (MDFA) has launched its new Research Impact Report, which showcases the groundbreaking projects our organisation has funded to help reduce the impact of macular disease.
Read moreMacular Disease Foundation Australia responds to the Australian Government’s planned MBS change
The Federal Government has announced that from 1 July 2025, people receiving sight-saving eye (intravitreal) injections to treat macular disease will no longer receive health fund benefits for this treatment if it is performed in private hospitals and day surgeries.
Read moreMeet your team behind the new Eye Connect support service
Dilini is one of MDFA’s Health Promotion Officers supporting people with age-related macular degeneration through our new Eye Connect service. A qualified Vision Scientist and training Optometrist, let’s find out more about Dilini and her experiences helping people with macular disease, Australia’s leading cause of blindness.
Read moreVision Voice: Read our latest newsletter
Welcome to the Spring 2024 edition of Vision Voice.
-
Read more
The Hon. Jillian Skinner AM becomes MDFA Ambassador
MDFA is pleased to announce that NSW government’s former Minister for Health and Minister for Medical research, the Hon. Jillian Skinner AM, has joined as our newest Ambassador.
Read moreCooking up a new stage of life: Shane Somerville tells his story
In our latest edition of Vision Voice, Shane candidly shares his experience of managing vision loss while still working, as well as maintaining a positive and busy life after his career.
Read moreNew Eye Connect service launched
Comedian Bron Lewis stars in new MDFA community service video
Read moreHealthy eating, healthy eyes.
It’s all very painless really. And your eyes might be grateful.
Most recent
MDFA response to Federal Budget announcement 2025-26
Macular Disease Foundation Australia (MDFA) is pleased with the Federal Government’s increased investment to make primary health care more affordable and accessible for Australians doing it tough due to the current cost of living crisis.
Our latest edition of Vision Voice is here
Welcome to the latest edition of Vision Voice.
Government defers MBS private health insurance reclassification
Macular Disease Foundation Australia (MDFA) has welcomed the Federal Government’s decision to defer the private health insurance reclassification of intravitreal (eye) injections from 1 July 2025 to 1 July 2026 and undertake further consultation.
Call to Federal Government to bulk bill eye injections for pensioners
We have released new research in collaboration with the University of New South Wales which has revealed the median total cost for people living with macular disease, who also receive sight-saving eye injections, is 12 percent* ($3,621) of the annual government pension payment.
Opinion Editorial: Sight preservation should be a national priority
By The Hon. Jillian Skinner, AM, former NSW Minister for Health.This article was originally published by News Corp.
Living with macular disease consumes 12% of age pension payments
Macular Disease Foundation Australia calls on the next Federal Government to bulk-bill sight-saving eye injections for pensioners; with the potential for creating a $140 million cost-saving per year.
New treatment for Geographic Atrophy
The Therapeutic Goods Administration (TGA) approval of the new eye injection treatment SYFOVRE® (pegcetacoplan) is welcome news, as it will give many people with Geographic Atrophy a treatment option that they’ve never had before to slow the progression of the disease.
Read our latest newsletter today
Welcome to our final Vision Voice newsletter for the year.
Survey shows new Eye Connect service benefiting AMD community
MDFA has received a positive response from the people participating in our new Eye Connect support service.